Compounding Pharmacy Market Report

Table of Contents

1 Methodology and Scope

• 1.1 Market Segmentation & Scope

• 1.1.1 Technology Type

• 1.1.2 Product

• 1.1.3 Application

• 1.1.4 Regional scope

• 1.1.5 Estimates and forecast timeline

• 1.2 Research Methodology

• 1.3 Information Procurement

• 1.3.1 Purchased database

• 1.3.2 Internal database

• 1.3.3 Secondary sources

• 1.3.4 Primary research

• 1.3.5 Details of primary research

• 1.4 Information or Data Analysis

• 1.4.1 Data analysis models

• 1.5 Market Formulation & Validation

• 1.6 Model Details

• 1.6.1 Commodity flow analysis

• 1.6.2 Volume price analysis

• 1.7 List of Secondary Sources

• 1.8 List of Abbreviations

2 Executive Summary

• 2.1 Market Outlook

• 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

• 3.1 Market Lineage Outlook

• 3.1.1 Parent market outlook

• 3.1.2 Ancillary market outlook

• 3.2 Market Segmentation

• 3.2.1 Analysis

• 3.3 Market Dynamics

• 3.3.1 Market driver analysis

• 3.3.2 Market restraint analysis

• 3.3.3 Industry opportunities

• 3.4 Penetration & Growth Prospect Mapping

• 3.4.1 Penetration & growth prospect mapping analysis

• 3.5 Business Environment Analysis Tools

• 3.5.1 Porter's five forces analysis

• 3.5.2 PESTLE analysis

• 3.5.3 Major deals & strategic alliances analysis

4 Compounding Pharmacy Market: Technology Type Analysis

• 4.1 Compounding Pharmacy Technology Type Market Share Analysis, 2018 & 2026

• 4.2 Compounding Pharmacy Technology Type Market: Segment Dashboard

• 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

• 4.3.1 503A compounding pharmacy

• 4.3.2 503B compounding pharmacy

5 Compounding Pharmacy Market: Product Analysis

• 5.1 Compounding Pharmacy Product Market Share Analysis, 2018 & 2026

• 5.2 Compounding Pharmacy Product Market: Segment Dashboard

• 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Compounding Pharmacy Market: Application Analysis

• 6.1 Compounding Pharmacy Application Market Share Analysis, 2018 & 2026

• 6.2 Compounding Pharmacy Application Market: Segment Dashboard

• 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

• 6.3.1 Paediatric

• 6.3.2 Adult

• 6.3.3 Geriatric

• 6.3.4 Veterinary

7 Compounding Pharmacy Market: Regional Analysis

• 7.1 Compounding Pharmacy Regional Market Share Analysis, 2018 & 2026

• 7.2 Compounding Pharmacy Regional Market: Segment Dashboard

• 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

• 7.4 List of Players at Regional Level

• 7.4.1 North America

• 7.4.2 Europe

• 7.4.3 Asia Pacific

• 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

• 7.5.1 North America

• 7.5.2 Europe

• 7.5.3 Asia Pacific

• 7.5.4 Latin America

• 7.5.5 MEA

• 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

• 7.6.1 North America

• 7.6.2 Europe

• 7.6.3 Asia Pacific

• 7.6.4 Latin America

• 7.6.5 Middle East & Africa

8 Competitive Analysis

• 8.1 Recent Developments & Impact Analysis, by Key Market Participants

• 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

• 8.3 Vendor Landscape

• 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

• 9.1 Fagron
  

• 9.1.1 Fagron Company overview

• 9.1.2 Financial performance

• 9.1.3 Product benchmarking

• 9.1.4 Strategic initiatives

• 9.1.5 SWOT analysis

• 9.2 ICU Medical
  

• 9.2.1 ICU Medical Company overview

• 9.2.2 Financial performance

• 9.2.3 Product benchmarking

• 9.2.4 Strategic initiatives

• 9.2.5 SWOT analysis

• 9.3 Pentec Health
  

• 9.3.1 Pentec Health Company overview

• 9.3.2 Financial performance

• 9.3.3 Product benchmarking

• 9.3.4 Strategic initiatives

• 9.3.5 SWOT analysis

• 9.4 Rx3 Compounding Pharmacy
  

• 9.4.1 Rx3 Compounding Pharmacy Company overview

• 9.4.2 Financial performance

• 9.4.3 Product benchmarking

• 9.4.4 Strategic initiatives

• 9.4.5 SWOT analysis

• 9.5 Cantrell Drug
  

• 9.5.1 Cantrell Drug Company overview

• 9.5.2 Financial performance

• 9.5.3 Product benchmarking

• 9.5.4 Strategic initiatives

• 9.5.5 SWOT analysis

• 9.6 Dougherty’s Pharmacy
  

• 9.6.1 Dougherty’s Pharmacy Company overview

• 9.6.2 Financial performance

• 9.6.3 Product benchmarking

• 9.6.4 Strategic initiatives

• 9.6.5 SWOT analysis

• 9.7 B. Braun Medical
  

• 9.7.1 B. Braun Medical Company overview

• 9.7.2 Financial performance

• 9.7.3 Product benchmarking

• 9.7.4 Strategic initiatives

• 9.7.5 SWOT analysis

• 9.8 Wedgewood Pharmacy
  

• 9.8.1 Wedgewood Pharmacy Company overview

• 9.8.2 Financial performance

• 9.8.3 Product benchmarking

• 9.8.4 Strategic initiatives

• 9.8.5 SWOT analysis

• 9.9 Wedgewood Pharma
  

• 9.9.1 Wedgewood Pharma Company overview

• 9.9.2 Financial performance

• 9.9.3 Product benchmarking

• 9.9.4 Strategic initiatives

• 9.9.5 SWOT analysis

• 9.10 Lorraine’s Pharmacy
  

• 9.10.1 Lorraine’s Pharmacy Company overview

• 9.10.2 Financial performance

• 9.10.3 Product benchmarking

• 9.10.4 Strategic initiatives

• 9.10.5 SWOT analysis

• 9.11 Pencol Compounding Pharmacy
  

• 9.11.1 Pencol Compounding Pharmacy Company overview

• 9.11.2 Financial performance

• 9.11.3 Product benchmarking

• 9.11.4 Strategic initiatives

• 9.11.5 SWOT analysis

• 9.12 Institutional Pharmacy Solutions
  

• 9.12.1 Institutional Pharmacy Solutions Company overview

• 9.12.2 Financial performance

• 9.12.3 Product benchmarking

• 9.12.4 Strategic initiatives

• 9.12.5 SWOT analysis

• 9.13 Village Compounding Pharmacy
  

• 9.13.1 Village Compounding Pharmacy Company overview

• 9.13.2 Financial performance

• 9.13.3 Product benchmarking

• 9.13.4 Strategic initiatives

• 9.13.5 SWOT analysis

• 9.14 PharMEDium Services
  

• 9.14.1 PharMEDium Services Company overview

• 9.14.2 Financial performance

• 9.14.3 Product benchmarking

• 9.14.4 Strategic initiatives

• 9.14.5 SWOT analysis

• 9.15 McGuff Compounding Pharmacy Services
  

• 9.15.1 McGuff Compounding Pharmacy Services Company overview

• 9.15.2 Financial performance

• 9.15.3 Product benchmarking

• 9.15.4 Strategic initiatives

• 9.15.5 SWOT analysis

• 9.16 McKesson Corporation
  

• 9.16.1 McKesson Corporation Company overview

• 9.16.2 Financial performance

• 9.16.3 Product benchmarking

• 9.16.4 Strategic initiatives

• 9.16.5 SWOT analysis

• 9.17 Wells Pharmacy Network
  

• 9.17.1 Wells Pharmacy Network Company overview

• 9.17.2 Financial performance

• 9.17.3 Product benchmarking

• 9.17.4 Strategic initiatives

• 9.17.5 SWOT analysis

• 9.18 Nephron Pharmaceuticals
  

• 9.18.1 Nephron Pharmaceuticals Company overview

• 9.18.2 Financial performance

• 9.18.3 Product benchmarking

• 9.18.4 Strategic initiatives

• 9.18.5 SWOT analysis

• 9.19 PCCA
  

• 9.19.1 PCCA Company overview

• 9.19.2 Financial performance

• 9.19.3 Product benchmarking

• 9.19.4 Strategic initiatives

• 9.19.5 SWOT analysis

• 9.20 Central Compounding Center
  

• 9.20.1 Central Compounding Center Company overview

• 9.20.2 Financial performance

• 9.20.3 Product benchmarking

• 9.20.4 Strategic initiatives

• 9.20.5 SWOT analysis

• 9.21 RXQ Compounding Pharmacy
  

• 9.21.1 RXQ Compounding Pharmacy Company overview

• 9.21.2 Financial performance

• 9.21.3 Product benchmarking

• 9.21.4 Strategic initiatives

• 9.21.5 SWOT analysis

• 9.22 Olympia Pharmacy
  

• 9.22.1 Olympia Pharmacy Company overview

• 9.22.2 Financial performance

• 9.22.3 Product benchmarking

• 9.22.4 Strategic initiatives

• 9.22.5 SWOT analysis

• 9.23 Clinigen Group
  

• 9.23.1 Clinigen Group Company overview

• 9.23.2 Financial performance

• 9.23.3 Product benchmarking

• 9.23.4 Strategic initiatives

• 9.23.5 SWOT analysis

• 9.24 Baxter
  

• 9.24.1 Baxter Company overview

• 9.24.2 Financial performance

• 9.24.3 Product benchmarking

• 9.24.4 Strategic initiatives

• 9.24.5 SWOT analysis

• 9.25 Premier Pharmacy Labs
  

• 9.25.1 Premier Pharmacy Labs Company overview

• 9.25.2 Financial performance

• 9.25.3 Product benchmarking

• 9.25.4 Strategic initiatives

• 9.25.5 SWOT analysis

• 9.26 Absolute Pharmacy
  

• 9.26.1 Absolute Pharmacy Company overview

• 9.26.2 Financial performance

• 9.26.3 Product benchmarking

• 9.26.4 Strategic initiatives

• 9.26.5 SWOT analysis

The List of Tables and Figures (Totals 65 Figures and 127 Tables)

• Figure 503A compounding pharmacy Compounding Pharmacy market, 2015 - 2026 (USD Million)

• Figure 503B compounding pharmacy Compounding Pharmacy market, 2015 - 2026 (USD Million)

• Figure Paediatric market, 2015 - 2026 (USD Million)

• Figure Adult market, 2015 - 2026 (USD Million)

• Figure Geriatric market, 2015 - 2026 (USD Million)

• Figure Veterinary market, 2015 - 2026 (USD Million)

• Table List of players in North America

• Table List of players in Europe

• Table List of players in Asia Pacific

• Table SWOT analysis

• Table North America Compounding Pharmacy market, by country, 2015 - 2026 (USD Million)

• Table North America Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table North America Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table North America Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table U.S. Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table U.S. Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table U.S. Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Canada Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table Canada Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table Canada Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Europe Compounding Pharmacy market, by country, 2015 - 2026 (USD Million)

• Table Europe Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table Europe Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table Europe Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table U.K. Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table U.K. Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table U.K. Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Germany Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table Germany Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table Germany Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table France Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table France Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table France Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Italy Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table Italy Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table Italy Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Spain Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table Spain Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table Spain Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Asia Pacific Compounding Pharmacy market, by country, 2015 - 2026 (USD Million)

• Table Asia Pacific Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table Asia Pacific Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table Asia Pacific Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table China Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table China Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table China Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Japan Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table Japan Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table Japan Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table India Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table India Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table India Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Latin America Compounding Pharmacy market, by country, 2015 - 2026 (USD Million)

• Table Latin America Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table Latin America Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table Latin America Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Brazil Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table Brazil Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table Brazil Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Mexico Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table Mexico Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table Mexico Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Argentina Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table Argentina Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table Argentina Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table MEA Compounding Pharmacy market, by country, 2015 - 2026 (USD Million)

• Table MEA Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table MEA Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table MEA Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table South Africa Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table South Africa Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table South Africa Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Regulatory scenario

• Table Nigeria Compounding Pharmacy market, by type, 2015 - 2026 (USD Million)

• Table Nigeria Compounding Pharmacy market, by product, 2015 - 2026 (USD Million)

• Table Nigeria Compounding Pharmacy market, by application, 2015 - 2026 (USD Million)

• Table Recent Developments & Impact Analysis, by Key Market Participants

• Table Recent Developments & Impact Analysis, by Key Market Participants

• Table Company market position analysis

• Table Company Profiles

• Table Fagron Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table ICU Medical Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Pentec Health Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Rx3 Compounding Pharmacy Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Cantrell Drug Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Dougherty’s Pharmacy Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table B. Braun Medical Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Wedgewood Pharmacy Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Wedgewood Pharma Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Lorraine’s Pharmacy Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Pencol Compounding Pharmacy Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Institutional Pharmacy Solutions Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Village Compounding Pharmacy Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table PharMEDium Services Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table McGuff Compounding Pharmacy Services Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table McKesson Corporation Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Wells Pharmacy Network Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Nephron Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table PCCA Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Central Compounding Center Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table RXQ Compounding Pharmacy Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Olympia Pharmacy Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Clinigen Group Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Baxter Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Premier Pharmacy Labs Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis

• Table Company Profiles

• Table Absolute Pharmacy Production, Value, Price, Gross Margin 2014-2019

• Table Product benchmarking

• Table Strategic initiatives

• Table SWOT analysis